6.260High5.910Low14.27MVolume6.220Open6.330Pre Close86.02MTurnover88.52%Turnover Ratio--P/E (Static)16.12MShares29.09752wk High--P/B97.50MFloat Cap5.25052wk Low0.43Dividend TTM16.12MShs Float19029.386Historical High7.14%Div YieldTTM5.53%Amplitude5.250Historical Low6.029Avg Price1Lot Size
With the Fed's September meeting likely to deliver a rate decrease, the question arises: how should investors allocate assets during an interest rate cut cycle...
This could be due to the fact that biotech and healthcare were nowhere near the top performers last year.
The defensive aspect of these sectors could be adding to their appeal since SPY is starting off 2024 on a bad foot.
If you like these sectors, then I suggest checking out the well-known large cap companies in these sectors as an investment prospect. Here are just a few...
No comment yet